Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. VYGR
VYGR logo

VYGR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Voyager Therapeutics Inc (VYGR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
3.720
1 Day change
2.76%
52 Week Range
5.550
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Voyager Therapeutics Inc (VYGR) does not present a strong buy opportunity for a beginner investor with a long-term strategy at this time. The technical indicators are mixed, with bearish moving averages and neutral RSI, while the options data suggests low put-call ratios but lacks significant volume to indicate strong sentiment. Additionally, there are no recent news catalysts, analyst updates, or financial data to support a compelling investment case. Given the lack of strong positive signals and the user's impatience for optimal entry points, holding off on this stock is recommended.

Technical Analysis

The MACD is positive and expanding, indicating potential bullish momentum. However, the RSI is neutral at 64.199, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 3.724), suggesting limited immediate upside. Overall, the technical indicators are mixed.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a bullish sentiment in the options market. However, the overall volume is low, and there is no significant activity to suggest strong investor interest.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
4

Positive Catalysts

  • The MACD histogram is positive and expanding, indicating potential bullish momentum. Low put-call ratios in options data suggest a slight bullish sentiment.

Neutral/Negative Catalysts

  • and neutral RSI indicate a lack of strong upward momentum. No recent news, financial data, or analyst updates to support a bullish case. Stock trend analysis predicts a slight decline over the next week and month.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target updates available.

Wall Street analysts forecast VYGR stock price to rise
7 Analyst Rating
Wall Street analysts forecast VYGR stock price to rise
7 Buy
0 Hold
0 Sell
Strong Buy
Current: 3.620
sliders
Low
8
Averages
13.2
High
25
Current: 3.620
sliders
Low
8
Averages
13.2
High
25
Morgan Stanley
Equal Weight
maintain
$25 -> $39
AI Analysis
2026-01-16
Reason
Morgan Stanley
Price Target
$25 -> $39
AI Analysis
2026-01-16
maintain
Equal Weight
Reason
Morgan Stanley raised the firm's price target on Voyager Technologies to $39 from $25 and keeps an Equal Weight rating on the shares. In the Infrastructure market of Space Technology, the recently-introduced Space Superiority Executive Order should prove supportive overall, but investors are monitoring the extent to which the objectives outlined tangibly impact the opportunity set, the analyst says.
H.C. Wainwright
H.C. Wainwright
Buy
downgrade
$30 -> $25
2025-11-12
Reason
H.C. Wainwright
H.C. Wainwright
Price Target
$30 -> $25
2025-11-12
downgrade
Buy
Reason
H.C. Wainwright lowered the firm's price target on Voyager Therapeutics to $25 from $30 and keeps a Buy rating on the shares. Voyager reported strong Q3 results, ending the quarter with $229M in cash and operational runway into 2028, while remaining eligible for up to $2.4B in partner milestones, the analyst tells investors in a research note. The company also advanced its NeuroShuttle non-viral delivery technology, with upcoming preclinical and trial data presentations expected to drive potential inflection points, the firm says.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for VYGR
Unlock Now

People Also Watch